Latest Strategy Changes News

Tasman Resources progresses exploration at Lake Torrens and Parkinson Dam projects while managing capital through a recent entitlement offer and loan repayments.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Cadoux Limited has made significant progress in developing its high purity alumina and rare earths projects, advancing engineering design, customer engagement, and funding strategies during the June 2025 quarter.

Fin Resources Limited is gearing up for a key geophysical survey at its McKenzie Springs copper-nickel-cobalt project while securing $445,000 in funding through convertible notes amid challenging market conditions.

EQ Resources delivered a robust Q4 FY2025 with strong tungsten output from its Spanish and Australian operations, bolstered by strategic capital raises and key plant enhancements.

Red Metal Limited’s June 2025 Quarterly Report highlights significant metallurgical advances at its Sybella rare earth project and accelerated drilling programs across copper-gold and gold targets, supported by government grants and resource upgrades.

Eden Innovations reports a striking 114% year-on-year jump in Q4 US sales of its EdenCrete® products, alongside a 50% annual sales increase and significant debt reduction plans.

Freehill Mining reported a transitional quarter marked by a dip in sales due to project cycles but offset by strategic site acquisitions and a successful capital raise. The company is poised for growth with new processing sites and promising magnetite test results.

Freehill Mining Ltd reported a challenging quarter ending June 2025 with net cash outflows from operations, but anticipates improved revenues from its Chilean operations as it ramps up activity.

Ramelius Resources has finalized its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders while expanding its board and asset portfolio. This move aims to accelerate Ramelius' growth toward becoming a half-million ounce gold producer within five years.

Carbonxt Group Limited advances its Kentucky activated carbon facility with increased ownership and imminent kiln commissioning, while securing $1 million in convertible notes to support growth. The company reports steady revenue and strong market positioning amid tightening US EPA PFAS regulations.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.